Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
Clinical trial NCT05406154 · UNKNOWN
Trial details
- NCT number
- NCT05406154
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-30
- Primary completion
- 2023-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.